The Transcriptional Landscape of BRAF Wild Type Metastatic Melanoma: A Pilot Study

Int J Mol Sci. 2022 Jun 21;23(13):6898. doi: 10.3390/ijms23136898.

Abstract

Melanoma is a relatively rare disease worldwide; nevertheless, it has a great relevance in some countries, such as in Europe. In order to shed some light upon the transcriptional profile of skin melanoma, we compared the gene expression of six independent tumours (all progressed towards metastatic disease and with wild type BRAF) to the expression profile of non-dysplastic melanocytes (considered as a healthy control) in a pilot study. Paraffin-embedded samples were manually micro-dissected to obtain enriched samples, and then, RNA was extracted and analysed through a microarray-based approach. An exhaustive bioinformatics analysis was performed to identify differentially expressed transcripts between the two groups, as well as enriched functional terms. Overall, 50 up- and 19 downregulated transcripts were found to be significantly changed in the tumour compared to the control tissue. Among the upregulated transcripts, the majority belonged to the immune response group and to the proteasome, while most of the downregulated genes were related to cytosolic ribosomes. A Gene Set Enrichment Analysis (GSEA), along with the RNA-Seq data retrieved from the TCGA/GTEx databases, confirmed the general trend of downregulation affecting cytoribosome proteins. In contrast, transcripts coding for mitoribosome proteins showed the opposite trend.

Keywords: metastatic melanoma; microdissection; ribosomes; transcriptomics; wild type BRAF.

MeSH terms

  • Humans
  • Melanocytes / metabolism
  • Melanoma* / enzymology
  • Melanoma* / genetics
  • Melanoma* / metabolism
  • Melanoma* / pathology
  • Neoplasm Metastasis
  • Pilot Projects
  • Proto-Oncogene Proteins B-raf* / genetics
  • Proto-Oncogene Proteins B-raf* / metabolism
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / metabolism

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf